IDH1 Mutation Clinical Trials in Miami, Florida
2 recruitingMiami, Florida
Showing 1–2 of 2 trials
Recruiting
Phase 2
Olutasidenib, Venetoclax, and Azacitidine in IDH1 Mutated Newly Diagnosed Acute Myeloid Leukemia Patients Eligible for Intensive Induction Chemotherapy
Acute Myeloid LeukemiaIDH1 Mutation
Justin Watts, MD16 enrolled1 locationNCT06782542
Recruiting
Phase 3
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Servier Bio-Innovation LLC136 enrolled114 locationsNCT06127407